Skip to content

Abnormal visceral sensitivity and the regulatory role of transcutaneous electrical acustimulation in diabetic gastrointestinal dysfunction

Abnormal visceral sensitivity and the regulatory role of transcutaneous electrical acustimulation in diabetic gastrointestinal dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000596
Enrollment
Unknown
Registered
2024-10-22
Start date
2021-10-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic gastrointestinal dysfunction

Interventions

Health control group:None
Test group:Transcutaneous electrical acustimulation (TEA)

Sponsors

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years old; 2. Patients with type 2 diabetes treated in the endocrinology department meet the diagnostic criteria of the 2020 Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes; 3. Diagnosis of gastrointestinal dysfunction according to Rome IV criteria.

Exclusion criteria

Exclusion criteria: 1. Patients with type 1 diabetes mellitus and uncontrolled blood glucose greater than 300mg/dl; 2. Patients with symptoms related to gastrointestinal dysfunction before the onset of diabetes; 3. Previous history of gastrointestinal organic diseases gastrointestinal surgery and spinal surgery; 4. Serious cardiovascular and cerebrovascular diseases and other systemic organ diseases: such as spinal cord injury malignant tumor etc.; 5. Severe mental disorder and cognitive dysfunction; 6. Patients with primary autonomic dysfunction; 7. Breastfeeding and pregnant women; 8. Skin allergic to the electrode.

Design outcomes

Primary

MeasureTime frame
Gastrointestinal Symptoms Rating Scale (GSRS);Gastrointestinal quality of life score (GIQOL);Fasting blood glucose;visceral sensitivity index (VSI);

Secondary

MeasureTime frame
Hospital anxiety and depression scores (HADS);Autonomic nervous function test;Gastrointestinal motility and sensory parameters;

Countries

China

Contacts

Public ContactLiuqin Jiang

The First Affiliated Hospital of Nanjing Medical University

jiangliuqin@163.com+86 139 5101 7379

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026